Harm reduction for AAS-using clients requires a structured, evidence-based monitoring protocol — not reactive panic when values look alarming. This guide provides a practical framework for pre-cycle baseline testing, on-cycle monitoring frequency, and post-cycle recovery assessment with clear action thresholds.
Establish a full baseline panel (hormonal, hematologic, hepatic, lipid, metabolic, renal) before any cycle begins
On-cycle monitoring schedule: hematologic panel at 4 and 8 weeks; hepatic panel at 4 weeks for orals
Clear stop/refer thresholds: hematocrit >54%, ALT >3× ULN, HDL <25 mg/dL, systolic BP >150 mmHg
Post-cycle recovery testing at 6–8 weeks off to verify HPTA recovery, lipid normalization, and organ function
Document longitudinal trends — a single out-of-range value is less meaningful than a trajectory of worsening
Give your clients professional bloodwork analysis with TRT-specific reference ranges, longitudinal trend tracking, and structured harm reduction insights — all under your coaching umbrella.
GearCheck provides blood marker analysis and harm reduction education. Information is for educational purposes only and does not constitute medical advice. Always consult a healthcare professional.